U.S. Markets closed

Novelion Therapeutics Inc. (NVLN)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
0.68000.0000 (0.00%)
At close: 9:40AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.6800
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's Range0.6800 - 0.6800
52 Week Range0.6800 - 0.6800
VolumeN/A
Avg. VolumeN/A
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.50
  • GlobeNewswire

    Novelion Therapeutics Provides Update on Liquidation Process

    Novelion Therapeutics Inc. (“Novelion” or the “Company”) by Alvarez & Marsal Canada Inc., Novelion’s court appointed liquidator (the “Liquidator”) today provides an update on the Company’s voluntary liquidation process (the “Liquidation”) that started on January 16, 2020 (the “Effective Date”). The Liquidator continues to believe that it will be able to complete a distribution in the fourth quarter of 2020, subject to the resolution of claims and other ongoing administrative matters including the finalization of tax returns and related matters in Canada and the U.S., but will provide further information to shareholders in the coming weeks.